# Serina Therapeutics (SER) — Earnings

SER · AMEX · Stock

Canonical page: https://www.lighthorse.io/tickers/ser/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2025 |
| Period end | Jun 30, 2025 |
| EPS actual | −$0.66 |
| EPS estimate | −$0.43 |
| EPS surprise | −55.29% |
| Revenue surprise | +0.00% |
| Revenue | $130,000.00 |
| Revenue estimate | $0.00 |
| Reported | Aug 11, 2025 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1708599/000170859925000089/ser-20250630.htm) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2025 | Aug 11, 2025 | −$0.43 | −$0.66 | -55.29% | — | $130,000.00 |
| Q1 2025 | May 8, 2025 | −$0.62 | −$0.49 | 20.97% | — | — |

## Frequently Asked Questions

### When did Serina Therapeutics (SER) last report earnings?

Serina Therapeutics last reported on Aug 11, 2025, covering fiscal Q2 2025.

### Did SER beat earnings estimates?

No. Serina Therapeutics reported EPS of −$0.66 for Q2 2025 against a −$0.43 estimate — a 55.29% miss.

### How much revenue did SER report last quarter?

Serina Therapeutics reported $130,000.00 in revenue for Q2 2025.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).